GPR119 Agonist for Hypoglycemia in Type 1 Diabetes

NCT04432090 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Placebo
DRUG: Study Medication (MBX-2982)
OTHER: No medication for this group

Sponsor

AdventHealth Translational Research Institute